Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer

A. Gadducci, M. Bruzzone, F. Carnino, N. Ragni, A. Rubagotti, P. F. Conte

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences